The Auto-Inhibitory Role of the EPAC Hinge Helix as Mapped by NMR

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Selvaratnam, Rajeevan ^a   Mazhab Jafari, Mohammad T ^a   Das, Rahul ^a   Melacini, Giuseppe ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP BINDING PROTEIN;

ALLOSTERISM; ALPHA HELIX; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISSOCIATION CONSTANT; ENZYME INHIBITION; GENE DELETION; GENE MAPPING; NUCLEAR MAGNETIC RESONANCE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; CYCLIC AMP; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 84869746585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048707     Document Type: Article

References (40)

1. Kannan N, Wu J, Anand GS, Yooseph S, Neuwald AF, et al. (2007) Evolution of allostery in the cyclic nucleotide binding module. Genome Biol 8(12) R264: 10.1186/gb-2007-8-12-r264.
2. Kornev AP, Taylor SS, Ten Eyck LF, (2008) A generalized allosteric mechanism for cis-regulated cyclic nucleotide binding domains. PLoS Comput Biol 4(4): e1000056.
3. Rehmann H, Wittinghofer A, Bos JL, (2007) Capturing cyclic nucleotides in action: Snapshots from crystallographic studies. Nat Rev Mol Cell Biol 8(1): 63-73.
4. McKay DB, Steitz TA, (1981) Structure of catabolite gene activator protein at 2.9 A resolution suggests binding to left-handed B-DNA. Nature 290(5809): 744-749.
5. Popovych N, Tzeng SR, Tonelli M, Ebright RH, Kalodimos CG (2009) Structural basis for cAMP-mediated allosteric control of the catabolite activator protein. Proc Natl Acad Sci U S A.
6. Esposito V, Sjoberg T, Das R, Brown S, Taylor SS, et al. (2006) NMR assignment of the cAMP-binding domain A of the PKA regulatory subunit RID A-3261-2009. J Biomol NMR 36 64-64: 10.1007/s10858-006-9050-9.
7. Berman HM, Ten Eyck LF, Goodsell DS, Haste NM, Kornev A, et al. (2005) The cAMP binding domain: An ancient signaling module. Proc Natl Acad Sci U S A 102(1) 45-50: 10.1073/pnas.0408579102.
8. Das R, Melacini G, (2007) A model for agonism and antagonism in an ancient and ubiquitous cAMP-binding domain. J Biol Chem 282(1): 581-593.
9. Das R, Esposito V, Abu-Abed M, Anand GS, Taylor SS, et al. (2007) cAMP activation of PKA defines an ancient signaling mechanism. Proc Natl Acad Sci U S A 104(1): 93-98.
10. Das R, Chowdhury S, Mazhab-Jafari MT, Sildas S, Selvaratnam R, et al. (2009) Dynamically driven ligand selectivity in cyclic nucleotide binding domains. J Biol Chem 284(35) pp. 23682-23696: 10.1074/jbc.M109.011700.
11. Masterson LR, Cheng C, Yu T, Tonelli M, Kornev A, et al. (2010) Dynamics connect substrate recognition to catalysis in protein kinase A. Nat Chem Biol 6(11). 821-828: 10.1038/nchembio.452.
12. Kim C, Cheng CY, Saldanha SA, Taylor SS, (2007) PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 130(6) 1032-1043: 10.1016/j.cell.2007.07.018.
13. Kim JJ, Casteel DE, Huang G, Kwon TH, Ren RK, et al. (2011) Co-crystal structures of PKG ibeta (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding. PLoS One 6(4) e18413: 10.1371/journal.pone.0018413.
14. Masterson LR, Mascioni A, Traaseth NJ, Taylor SS, Veglia G, (2008) Allosteric cooperativity in protein kinase A. Proc Natl Acad Sci U S A 105(2). 506-511: 10.1073/pnas.0709214104.
15. Das R, Abu-Abed M, Melacini G, (2006) Mapping allostery through equilibrium perturbation NMR spectroscopy. J Am Chem Soc 128(26): 8406-8407.
16. Anand GS, Krishnamurthy S, Bishnoi T, Kornev A, Taylor SS, et al. (2010) Cyclic AMP- and (rp)-cAMPS-induced conformational changes in a complex of the catalytic and regulatory (RI{alpha}) subunits of cyclic AMP-dependent protein kinase. Mol Cell Proteomics 9(10) 2225-2237: 10.1074/mcp.M900388-MCP200.
17. Badireddy S, Yunfeng G, Ritchie M, Akamine P, Wu J, et al. (2011) Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: Conformational selection highlights a new concept in allosteric inhibitor design. Mol Cell Proteomics 10(3) M110 (004390) ():: 10.1074/mcp.M110.004390.
18. McNicholl ET, Das R, SilDas S, Taylor SS, Melacini G, (2010) Communication between tandem cAMP binding domains in the regulatory subunit of protein kinase A-ialpha as revealed by domain-silencing mutations. J Biol Chem 285(20) 15523-15537: 10.1074/jbc.M110.105783.
19. Chow SS, Van Petegem F, Accili EA, (2012) Energetics of cyclic AMP binding to HCN channel C terminus reveal negative cooperativity. J Biol Chem 287(1) 600-606: 10.1074/jbc.M111.269563.
20. Zagotta WN, Olivier NB, Black KD, Young EC, Olson R, et al. (2003) Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature 425(6954): 200-205.
21. Das R, Mazhab-Jafari MT, Chowdhury S, SilDas S, Selvaratnam R, et al. (2008) Entropy-driven cAMP-dependent allosteric control of inhibitory interactions in exchange proteins directly activated by cAMP. J Biol Chem 283(28): 19691-19703.
22. Rehmann H, Rueppel A, Bos JL, Wittinghofer A, (2003) Communication between the regulatory and the catalytic region of the cAMP-responsive guanine nucleotide exchange factor epac. J Biol Chem 278(26): 23508-23514.
23. Rehmann H, Prakash B, Wolf E, Rueppel A, de Rooij J, et al. (2003) Structure and regulation of the cAMP-binding domains of Epac2. Nat Struct Biol 10(1): 26-32.
24. Mazhab-Jafari MT, Das R, Fotheringham SA, SilDas S, Chowdhury S, et al. (2007) Understanding cAMP-dependent allostery by NMR spectroscopy: Comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states. J Am Chem Soc 129(46): 14482-14492.
25. Rehmann H, Das J, Knipscheer P, Wittinghofer A, Bos JL, (2006) Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 439(7076): 625-628.
26. Selvaratnam R, Chowdhury S, VanSchouwen B, Melacini G, (2011) Mapping allostery through the covariance analysis of NMR chemical shifts. Proc Natl Acad Sci U S A 108(15) 6133-6138: 10.1073/pnas.1017311108.
27. Selvaratnam R, Vanschouwen B, Fogolari F, Mazhab-Jafari MT, Das R, et al. (2012) The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants. Biophys J 102(3) 630-639: 10.1016/j.bpj.2011.12.030.
28. Rehmann H, Arias-Palomo E, Hadders MA, Schwede F, Llorca O, et al. (2008) Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455(7209): 124-127.
29. Zheng L, Stathopulos PB, Schindl R, Li GY, Romanin C, et al. (2011) Auto-inhibitory role of the EF-SAM domain of STIM proteins in store-operated calcium entry. Proc Natl Acad Sci U S A 108(4) 1337-1342: 10.1073/pnas.1015125108.
30. Hayashi I, Plevin MJ, Ikura M, (2007) CLIP170 autoinhibition mimics intermolecular interactions with p150Glued or EB1. Nat Struct Mol Biol 14(10) 980-981: 10.1038/nsmb1299.
31. VanSchouwen B, Selvaratnam R, Fogolari F, Melacini G, (2011) Role of dynamics in the autoinhibition and activation of the exchange protein directly activated by cyclic AMP (EPAC). J Biol Chem 286(49) pp. 42655-42669 10.1074/jbc.M111.277723.
32. Selvaratnam R, Akimoto M, VanSchouwen B, Melacini G, (2012) cAMP-dependent allostery and dynamics in epac: An NMR view. Biochem Soc Trans 40(1) 219-223: 10.1042/BST20110628.
33. Harper SM, Wienk H, Wechselberger RW, Bos JL, Boelens R, et al. (2008) Structural dynamics in the activation of epac. J Biol Chem 283(10) 6501-6508: 10.1074/jbc.M707849200.
34. Kraemer A, Rehmann HR, Cool RH, Theiss C, de Rooij J, et al. (2001) Dynamic interaction of cAMP with the rap guanine-nucleotide exchange factor Epac1. J Mol Biol 306(5) 1167-1177: 10.1006/jmbi.2001.4444.
35. Viste K, Kopperud RK, Christensen AE, Doskeland SO, (2005) Substrate enhances the sensitivity of type I protein kinase a to cAMP. J Biol Chem 280(14) 13279-13284: 10.1074/jbc.M413065200.
36. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) Nmrpipe- a multidimensional spectral processing system based on unix pipes. J Biomol NMR 6(3): 277-293.
37. Goddard TD, Kneller DG (2004) SPARKY. Version 3. University of California, San Francisco.
38. Sattler M, Schleucher J, Griesinger C, (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog Nucl Magn Reson Spectrosc 34(2): 93-158.
39. Aden J, Wolf-Watz M, (2007) NMR identification of transient complexes critical to adenylate kinase catalysis. J Am Chem Soc 129(45): 14003-14012.
40. Stockman B, Dalvit C, (2002) NMR screening techniques in drug discovery and drug design. Prog Nucl Magn Reson Spectrosc 41(3-4) 187-231: 10.1016/S0079-6565(02)00049-3.